a:head signs license and collaboration agreements with IMBA,
in addition is awarded funding from FFG.
Wien, October 24, 2019 (OTS) - a:head bio AG today announced a long-term partnership with the Institute of Molecular Biotechnology (IMBA) in Vienna, Austria for the development of next generation central nervous system (CNS) therapeutics and the award of an Early Stage grant from the Austrian Research Promotion Agency (FFG).
Under the terms of the agreements, a:head will be granted an exclusive, worldwide license on IMBAs cerebral organoid intellectual property and!-->!-->!-->…